CD4-BFFI

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCD4-BFFI
Drug Alias NameCD4-BFFI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransmembrane glycoprotein gp41 inhibitorsAnti-CD4
TargetsT-cell surface antigen CD4Transmembrane glycoprotein gp41
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A